Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors
Authors:
Open Access
- 5 November 2022
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 240, 154200
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013
- The Role of Desmoglein-3 in the Diagnosis of Squamous Cell Carcinoma of the LungThe American Journal of Pathology, 2009
- Squamous cell carcinoma arising in mature cystic teratoma of the ovary: an immunohistochemical analysis of its tumorigenesisHistopathology, 2007
- DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesisOncogene, 2006
- Influence of slide aging on results of translational research studies using immunohistochemistryLaboratory Investigation, 2004
- Differential Effects of Desmoglein 1 and Desmoglein 3 on Desmosome FormationJournal of Investigative Dermatology, 2002
- Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studiesThe Journal of Pathology, 2001
- Validation of Tissue Microarrays for Immunohistochemical Profiling of Cancer Specimens Using the Example of Human Fibroblastic TumorsThe American Journal of Pathology, 2001
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Thymic Carcinoma A Clinicopathologic Study of 13 CasesAmerican Journal of Surgical Pathology, 1990